Clinical factors associated with cytokine release syndrome and dosing recommendations for restarting elranatamab following an interruption Meeting Abstract
| Authors: | Niesvizky, R.; Arnulf, B.; Mohty, M.; Nooka, A. K.; Manier, S.; Tomasson, M.; Bahlis, N. J.; Irby, D.; Hibma, J.; Viqueira, A.; Leip, E.; Lesokhin, A. |
| Abstract Title: | Clinical factors associated with cytokine release syndrome and dosing recommendations for restarting elranatamab following an interruption |
| Meeting Title: | 65th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 142 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Dec 9-12 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2023-11-02 |
| Start Page: | 3384 |
| Language: | English |
| ACCESSION: | WOS:001159740303247 |
| DOI: | 10.1182/blood-2023-182166 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
